Early Pregnancy Bleeding Notes
Early Pregnancy Bleeding Notes
Early Pregnancy Bleeding Notes
Clinical history
1. CC+HOPI:
PV bleeding
Vaginal discharge
Abdominal pain
Mass in abdomen
2. Systemic Review
3. Menstrual history
4. PMH/PSH
5. Drug history
6. Past Obs history
7. Past Gynae history
8. Family history
9. Social History
Physical examination
Investigations
Etiological factors
- Chromosomal abnormalities
i. Autosomal trisomy
ii. Monosomy X
iii. Triploidy
- Medical/endocrine disorders
Endocrine factors
i. Hypothyroidism
ii. Diabetes mellitus
iii. Polycystic ovarian syndrome (PCOS)
Maternal medical illness
i. Diabetes mellitus
ii. Hypertension
iii. Thrombophilia
Immunological disorders
i. Anti-phospholipid syndrome
- Uterine abnormalities
i. Cervical incompetence
ii. Bicornuate/septate uterus
iii. Uterine fibroid
iv. Uterine synechiae
v. Placenta abruption
- Infections (any acute infection with high fever)
i. Herpes simplex
ii. Human papilloma virus (HPV)
iii. Chlamydia
iv. Malaria
- Drugs/chemicals (cytotoxic, cocaine, industrial chemical agents)
Anatomical abnormalities and maternal medical illness are etiological factors during
2nd trimesters while the rest are 1st trimester.
Differential diagnosis
Ectopic pregnancy
Local causes- vaginal tear from coitus, cervical ectropion, carcinoma of the cervix
Management
- Expectant management
i. Spontaneous miscarriage
ii. Avoid surgical intervention but may be required if there is heavy bleeding
- Medical management
i. Involves misoprostol (PGE analogue) or mifeprestione (progesterone
antagonist) SE: pain, vomiting, diarrhea
ii. Pain relief and antiemetics are prescribed
- Surgical management
i. Indication: persistent extensive bleeding/hemodynamic instability/ patient’s
choice
ii. Manual vacuum aspiration (local/general anesthetic)
iii. Suction curette insertion (vaginal/sublingual misoprostol dilate cervix) (but
we use Cervagem to dilate and soften the cervix)
iv. Evacuation of retained product of conception (ERPOC)- standard procedure
may cause complication such as cervical trauma, subsequent cervical
incompetence, uterine perforation, uterine adhesions or post op pelvic
infection.
Type of Management
miscarriage
Threatened Observation (expectant), pelvic rest, folic acid supplement and
luteal support
Inevitable Expectant, medical or surgical
• Principle of Management:
q Measures general condition of patient
q Accelerate process of expulsion
q Maintain strict asepsis
• General measures:
q Shock: Treat with IV fluid therapy and blood transfusion
q Excessive bleeding: Administer Ergometrine or Syntometrine
• Active treatment:
q Await spontaneous expulsion
q Augmentation with oxytocin
Complete Supportive
• Product of conception is sent to verify intrauterine
pregnancy
• Observe patient for any further bleeding or signs of infection
Missed Expectant, medical or surgical
• Uterus (<12 wks gestation):
q Vaginal evacuation done without delay
q Cervical os need to dilated first and followed by suction
evacuation under gen. anesthesia
• Uterus (>12 wks gestation):
q Induction can be done by oxytocin or prostaglandin
• Medication: Misoprostol, Mifepristone
q SE: Pain, vomiting and diarrhea
q Surgical evacuation is considered only after 7 days if patient
fails to respond.
Complications of miscarriage
Immediate:
- Major: anemia, hemorrhage, thromboembolism, operative trauma and infection
- Minor: lower abdominal pain, bleeding and pelvic infection
Late:
- Infertility
Physical examination
- Pallor, lower abdominal tenderness, guarding or rebound tenderness, PV bleeding,
adnexal mass and/or tenderness
- May present in shock with hypotension and abdominal distension
Spielberg’s criteria (ovarian pregnancy)
Investigation
- Urine pregnancy test: positive
i. intact ipsilateral tube clearly separates
- Speculum examination
from ovary
i. Cervical excitation positive
ii. gestation occupying normal position
- Pelvic Ultrasound scan
of ovary
i. To assess intrauterine pregnancy/extrauterine
iii. gestational sac connected to uterus
ii. Viability of the pregnancy
by utero-ovarian ligament
iii. Any adnexal mass
iv. ovarian tissue must be located in sac
iv. Any free fluid
wall
v. Any retained POC
vi. Assess endometrial thickness <15 mm (in complete miscarriage)
vii. Check if any mass at POD (pouch of Douglas)
## if ectopic pregnancy usually empty uterus, with adnexal mass at possible implantation
location.
- Serum BhCG level: suboptimal rise, plateau or fall between 48 hrs
- FBC (if Ddx is infection) (Hb, GXM)
- Laparoscopy
Differential diagnosis
Management
General
- Resuscitation (two iv access, large bore if hemodynamically unstable)
- Group and cross match blood
- Check blood group and rhesus. Give anti-D immunoglobulin if rhesus negative at a
dose of 250 iu (50 microgrammes)
Expectant management
- For patients who are hemodynamically stable and symptomatic
- Patient requires serial hCG measurements until levels are undetectable
Medical management
q Methotrexate
q Indications: minimal symptoms, adnexal mass <40mm in diameter, current
serum hCG <3000 IU/L
q MOA: folic acid antagonist inhibits DNA synthesis particularly affecting
trophoblastic cells
q SE: stomatitis, conjucativitis, GI upset, photosensitive skin reaction, non-
specific abdominal pain
q CI: chronic liver, renal or hematological disorder, active infection,
immunodeficiency, breastfeeding
q Other advices: avoid sexual intercourse during treatment, avoid conceiving
for 3 months after treatment, avoid alcohol and prolonged exposure to
sunlight during treatment
q After treatment, serum hCG level is routinely measured on day 4,7 and 11
then weekly thereafter until undetectable
Surgical management
- Laparoscopy: preferred approach
- Laparotomy: only done when there’s no endoscopic facilities or when the patient is
severely compromised (large hemoperitoneum, clinically unstable, dense pelvic
adhesions)
Gestational trophoblastic neoplasia (GTN)= subset of GTD with high serum BhCG in
the absence of normal pregnancy and need chemotherapy. This can arise following
molar or normal pregnancy
Investigations
i. Urine pregnancy test: positive
ii. Ultrasound examination of uterus: diagnosis of complete mole is almost always
made by +ve urine pregnancy test and with characteristics ultrasound findings
(multiple echoes seen within uterine cavity or so-called “snowstorm
appearance). Bilateral theca lutein cysts may be present. Diagnosis of partial
mole can be missed on scan.
iii. Serum BhCG (high in complete mole, low in partial mole)
iv. Full blood count (FBC) Hb level d/t PV bleeding, coagulation profile (PT, aPTT)
v. Serum electrolytes, creatinine and liver function tests (+/- thyroid function test)
vi. Blood group and rhesus status
vii. Chest X-ray- metastasis may be seen as either discrete, multiple or large solitary
lesions. There may be milliary pattern or pleural effusions.
viii. Imaging by MRI or CT scan is indicated only when ultrasound examination is
inconclusive or if suspect metastasis.
Management
i. GXM 2 to 4 pints of whole blood (as preparation for suction curettage)
ii. Suction evacuation followed by gentle blunt curettage should be performed as
soon as possible under anesthesia. Start Cervagem 1mg 3 hours before the
procedure and administer IV udoxan/ IM ergometrin to prevent excessive
bleeding and helps to minimize the risk of uterine perforation during the
procedure. Possible complications of the procedure are:
Hemorrhage
Uterine perforation
Trophoblastic tissue embolization to the lung
Sepsis
iii. Give anti-D immunoglobulin if rhesus negative within 72 hours of suction
curettage
iv. Repeat ultrasound examination of the uterine cavity in one week. If molar tissue,
still present, consider repeat suction curettage.
v. Follow up with serial BhCG as outpatient. Serum BhCG usually will drop to
normal within 8 to 12 weeks after evacuation of molar pregnancy. Outcome: 80%
will have spontaneous regression, 3-5% develop choriocarcinoma and 15% have
persistent mole. The need for chemothepray following a complete mole is 15-
20% and 0.5% after a partial mole.
Follow up
i. Weekly BhCG measurements should be done until it becomes
undetectable. Then two further specimens are obtained at weekly
intervals.
ii. Subsequently, the patient is tested monthly for 6 months and then at two
monthly intervals for a further 6 months to ensure that the BhCG levels
remain undetectable.
iii. If there is abnormal regression BhCG levels, look for locally invasive
disease in the uterus or metastasis to other sites.
iv. Women are advised to avoid pregnancy while on follow-up. Condom
usage are advised to avoid pregnancy for a further 6 months after the
serum BhCG levels has returned to normal value. The combined oral
contraceptive pills and HRT are safe to use if there is no other
contraindications after BhCG levels have reverted to normal. Sterilization
will be ideal if completed family.
v. Advise early ultrasound in next pregnancy because risk of recurrence is 1-
2%.
If diagnosis GTN, refer to FIGO scoring and staging. Appropriate chemotherapy +/-
surgery
• Score of 6 or less are at low risk and tend to have a good outlook regardless of how
far the cancer has spread. The tumor usually responds well to chemotherapy.
• Score of 7 or more are at high risk, and their tumors tend to respond less to
chemotherapy, even if they haven't spread much. They may require more intensive
chemotherapy.
Complication of GTD
- Thyrotoxicosis
- Persistent GTD
- Molar metastases
- Disseminated intravascular coagulation (DIC)
4. Other causes